Goldenwell Biotech (GWLL) Current Leases (2021 - 2022)

Goldenwell Biotech (GWLL) reported Current Leases of $25372.0 for Q4 2022, down 46.9% on a YoY basis from $47779.0 in Q4 2021, and down 12.89% quarter-over-quarter from $29126.0 in Q3 2022.

Goldenwell Biotech (GWLL) Current Leases (2021 - 2022) Analysis & Trends

Goldenwell Biotech has reported Current Leases for 2 years, with the latest figure at $25372.0 in Q4 2022.

  • For the quarter ending Q4 2022, Current Leases fell 46.9% year-over-year to $25372.0; the trailing twelve-month figure through Dec 2022 stood at $25372.0 (down 46.9% YoY), and the FY2022 full-year result was $25372.0, down 46.9% from the prior year.
  • Current Leases for Q4 2022 stood at $25372.0, down from $29126.0 in the prior quarter.
  • The five-year high for Current Leases was $47779.0 in Q4 2021, with the low at $17069.0 in Q1 2021.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Leases (Qtr)
1 Paranovus Entertainment Technology 75,216.52 Bn 75,216.52 Bn - 141,725.00
2 Kraft Heinz 26.76 Bn 22.68 Bn 2.22 Bn -
3 General Mills 17.79 Bn 17.02 Bn 1.37 Bn -
4 Jbs 13.93 Bn 9.37 Bn 2.32 Bn 1.42 Bn
5 Hormel Foods 13.00 Bn 12.16 Bn 518.51 Mn -
6 Mccormick 12.70 Bn 13.10 Bn 708.90 Mn -
7 Magnum Ice Cream 12.17 Bn 11.70 Bn - -
8 J M Smucker 11.05 Bn 10.99 Bn 827.80 Mn -
9 Smithfield Foods 10.57 Bn 9.49 Bn 511.00 Mn 73.00 Mn
10 Goldenwell Biotech - - 25,000.00 -

Historic Data

Download Data
DateValue
Dec 31, 2022 25,372.00
Sep 30, 2022 29,126.00
Jun 30, 2022 32,866.00
Mar 31, 2022 40,352.00
Dec 31, 2021 47,779.00
Sep 30, 2021 22,875.00
Jun 30, 2021 22,816.00
Mar 31, 2021 17,069.00